Why, if After 7 to 21 Years of Follow-Up Data, Disc Arthroplasty Has a Mere 0.67% Index Level Revision Rate, Is It Not a Standard of Care?

Key Takeaways

• 0.67% index-level revision rate over up to 21 years.
• ODI and VAS scores improved within 3 months and stayed low.
• Two-level disc replacement matched outcomes of single-level procedures.
• Patients with prior surgery achieved similar long-term pain relief.
• Adjacent-level surgery occurred in only 1.85% of cases.

Pulse Analysis

Lumbar total disc arthroplasty (TDA) entered the spine market as a motion‑preserving alternative to fusion, promising to maintain segmental flexibility and curb adjacent‑segment degeneration. Early trials demonstrated short‑term pain relief, but skeptics demanded evidence that implants could survive the rigors of daily loading for decades. Without robust longitudinal data, insurers and hospital committees often defaulted to fusion, citing its long‑track record. The recent 1,187‑patient cohort, followed for up to 21 years, finally provides the durability signal the specialty has been waiting for.

The study stratified patients into single‑ and two‑level TDA, with and without prior index‑level surgery, and tracked Oswestry Disability Index and Visual Analog Scale scores at regular intervals. Across all groups, disability scores dropped dramatically within three months and remained low for the full follow‑up, while back and leg pain followed the same trajectory. Only 49 patients (4.1%) required any reoperation, and the index‑level revision rate was a mere 0.67%, far below the 5‑10% rates typical of long‑term fusion cohorts. Adjacent‑level surgery occurred in just 1.85% of cases, reinforcing the theoretical advantage of motion preservation.

These findings could shift reimbursement policies and encourage wider adoption of disc prostheses, especially as the population ages and demand for motion‑preserving solutions rises. Device manufacturers may leverage the data to expand indications to multi‑level disease and to pursue next‑generation materials that further reduce wear. However, careful patient selection remains critical; the cohort excluded severe facet arthropathy and instability, conditions that still favor fusion. Ongoing registries and comparative trials will be needed to confirm that the low revision rates translate across diverse practice settings and newer implant designs.